Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9CGC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,564
Award facts
- Contract value 100% obligated
- $10,563.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,563.70 to AmerisourceBergen Drug Corp for 60-count tablets of Xifaxan 550 mg, an antibiotic medication commonly used to treat traveler's diarrhea and other gastrointestinal conditions. The award, issued on December 30, 2025, with a completion date of December 31, 2025, utilized firm fixed pricing and was not set aside for any specific category of vendors. The contract represents a competitive award to the prime contractor, reflecting the company's established capability to meet federal pharmaceutical procurement requirements. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contracting portfolio demonstrates its role as a major pharmaceutical distributor serving critical defense and veteran healthcare supply needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9CGC?
SPE2DR26F9CGC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F9CGC worth?
The government has obligated $10,564 on SPE2DR26F9CGC.
Is contract SPE2DR26F9CGC an order under another contract?
Yes. SPE2DR26F9CGC is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CGC competed?
The extent of competition for SPE2DR26F9CGC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award